跳到主要內容

臺灣博碩士論文加值系統

(34.204.181.91) 您好!臺灣時間:2023/09/28 08:49
字體大小: 字級放大   字級縮小   預設字形  
回查詢結果 :::

詳目顯示

: 
twitterline
研究生:蔡怡蓁
研究生(外文):Yi Chen Tsai
論文名稱:市場競爭對血液透析感染率之影響
論文名稱(外文):The Impact of Market Competition on Infections during Hemodialysis Treatment
指導教授:許績天許績天引用關係
指導教授(外文):J. T. Sheu
學位類別:碩士
校院名稱:長庚大學
系所名稱:醫務管理學系
學門:商業及管理學門
學類:醫管學類
論文種類:學術論文
論文出版年:2016
畢業學年度:104
語文別:中文
論文頁數:80
中文關鍵詞:市場競爭透析品質感染率固定半徑法賀芬達指數
外文關鍵詞:market competitionquality of dialysisrate of infectionsFixed Radius MethodHerfindahl-Hirschman Index
相關次數:
  • 被引用被引用:2
  • 點閱點閱:348
  • 評分評分:
  • 下載下載:62
  • 收藏至我的研究室書目清單書目收藏:0
過去有許多探討市場競爭與醫療品質之文獻,其結論卻不甚一致。近年來,台灣的透析人口數逐年增加,儘管過去有諸多討論透析品質之文章,但多數研究以存活分析和病人知覺品質等結果面作為品質之衡量,此衡量方式著重在病患之治療成效及其自身知覺品質。故本研究將以透析感染率作為過程面之品質指標,分析市場競爭對透析品質之影響。
本研究採固定半徑法來定義市場,並以賀芬達指數(HHI)衡量競爭程度。研究資料為2004~2011年健保資料庫重大傷病檔的門診資料,根據ICD-9確立病患是否有感染,並設立實證模型,以月和季作為時間單位,估計市場競爭對透析感染率的影響,以及當市場競爭程度變化時對感染率之影響。
研究結果指出,當市場的HHI愈高,病患感染機率較低,即市場競爭愈劇烈,病患的透析感染機率較高,透析品質較差,且該結果不因依變數為連續變數或間斷變數、市場半徑之定義不同和時間單位不同而有改變。透過本研究之結果,隨著透析院所的市場競爭加劇,透析品質卻下降,其中醫護人力是否不足或分配不均,進而影響病患之醫療品質,增加其感染的風險,值得衛生主管機關重視。

A large amount of literature has investigated the relationship between market competition and quality of medical care. However, the results from these studies are conflicting. Recently, the number of patients who receive dialysis treatment has been increasing year by year. Although many studies have previously investigated the quality of dialysis treatment, the majority of these studies focused on measuring the survival rate and satisfaction levels of patients as a means of measuring the quality of the dialysis treatment. These types of measurement determined only the outcome of treatment as well as the subjective opinions of patients. In this study, the rate of infections resulting from dialysis treatment was used as a measurement of treatment quality and the effect of market competition on quality of dialysis treatment was investigated.
The present study used the Fixed Radius Method to define market areas and the Herfindahl-Hirschman Index (HHI) to determine the level of market competition. Clinical data for the period of 2004 to 2011 were obtained from the Registry for Catastrophic Illness Patients, National Health Insurance Research Database. ICD-9 codes were used to determine if the patients suffered from infections. An empirical model was created, in which months and seasons were used as units of time, to estimate the effect of market competition on the rate of infection resulting from dialysis treatment. We measured the effect of changes in market competition on the rates of infection resulting from dialysis
Our study indicated that a higher HHI was related to a lower rate of infection. This means that for higher levels of market competition, the rates of infection would be higher and the quality of dialysis treatment would be lower. In addition, this result did not change when the dependent variables were continuous or discrete variables, when the defined market radius changed, or when different units of times were used. This study demonstrated that market competition amongst dialysis clinics led to reductions in the quality of dialysis treatment. It is worth recommending that major health departments further investigate whether the increased rate of infection resulting from dialysis treatment and hence, the reduced quality of medical care, was due to insufficient numbers of medical staff or insufficient staff allocation.

目 錄
指導教授推薦書…………………………………………………………
口試委員會審定書………………………………………………………
誌謝…………………………………………………………………………………iii
中文摘要…………………………………………………………………………iv
英文摘要………………………………………………………………………… v
第一章 緒論 - 1 -
第一節 研究背景與動機 - 1 -
第二節 研究目的 - 4 -
第二章 文獻探討 - 5 -
第一節 醫療市場競爭之測量 - 5 -
一、 市場範圍之界定 - 6 -
二、 市場競爭程度之測量 - 12 -
第二節 醫療市場之競爭型態 - 15 -
第三節 市場競爭與醫療品質 - 18 -
第四節 透析品質的評估 - 22 -
第三章 研究方法 - 24 -
第一節 實證模型 - 24 -
第二節 研究資料及變項說明 - 28 -
第四章 研究結果 - 32 -
第一節 描述性統計 - 32 -
第二節 估計結果 - 41 -
第五章 結論與建議 - 59 -
第一節 結論與討論 - 59 -
第二節 研究限制及建議 - 61 -
參考文獻 - 64 -

圖目錄
圖1-1 歷年各國ESRD之發生率與盛行率…………………………………. 2

表目錄
表2-1:不同市場範圍劃分方法之優缺點比較……………………………… 11
表2-2:競爭程度測量指標之優缺點比較…………………………………... 14
表2-3:國內外市場競爭與醫療品質之相關文獻…………………………... 21
表3-1:變項名稱及其定義說明…………………………………………… 31
表4-1:歷年ESRD透析病患特性……………………………………….. 36
表4-2:歷年ESRD透析感染病患特性……………………………………37
表4-3:歷年透析醫療院所數……………………………………………..38
表4-4:歷年透析市場百分比(依競爭程度) ………………………………. 39
表4-5歷年競爭市場之平均競爭家數(依競爭程度) ………………………. 40
表4-6:市場競爭程度對透析感染機率的影響分析結果(以月為單位) ……… 46
表4-7:市場競爭程度對透析感染機率的影響分析結果(以月為單位) ……….48
表4-8:市場競爭程度對透析感染機率的影響分析結果(以季為單位) ……….49
表4-9:市場競爭程度對透析感染機率的影響分析結果(以季為單位) ……….50
表4-10:不同市場競爭程度對透析感染機率的影響分析結果(以月為單位) … 51
表4-11:不同市場競爭程度對透析感染機率的影響分析結果(以月為單位) … 52
表4-12:不同市場競爭程度對透析感染機率的影響分析結果(以季為單位) … 53
表4-13:不同市場競爭程度對透析感染機率的影響分析結果(以季為單位) … 54
表4-14:市場競爭變化對透析感染機率的影響分析結果(以月為單位) ………55
表4-15:市場競爭變化對透析感染機率的影響分析結果(以月為單位) ………56
表4-16:市場競爭變化對透析感染機率的影響分析結果(以季為單位) ………57
表4-17:市場競爭變化對透析感染機率的影響分析結果(以季為單位) ………58


參考文獻
Baker, L. C. (2001). Measuring competition in health care markets. Health Services Research, 36(1 Pt 2), 223.
Chen, C.-C., & Cheng, S.-H. (2010). Hospital competition and patient-perceived quality of care: Evidence from a single-payer system in Taiwan. Health policy, 98(1), 65-73.
Donabedian, A.. (1966). Evaluating the Quality of Medical Care. The Milbank Memorial Fund Quarterly,44(3), 166–206.
Dranove, D., & Ludwick, R. (1999). Competition and pricing by nonprofit hospitals: a reassessment of Lynk's analysis. J Health Econ, 18(1), 99-116.
Dranove, D., Shanley, M., & White, W. D. (1993). Price and concentration in hospital markets: the switch from patient-driven to payer-driven competition. Journal of Law and Economics, 179-204.
Escarce, J. J., Jain, A. K., & Rogowski, J. (2006). Hospital competition, managed care, and mortality after hospitalization for medical conditions: Evidence from three states. Medical Care Research and Review, 63(6 suppl), 112S-140S.
Fayers PM, Machin D: Quality of life. Assessment, analysis and interpretation 2000 John Wiley & Sons Ltd.
Garnick, D. W., Luft, H. S., Robinson, J. C., & Tetreault, J. (1987). Appropriate measures of hospital market areas. Health Services Research, 22(1), 69.
Gaynor, M., & Vogt, W. B. (2000). Antitrust and competition in health care markets. Handbook of health economics, 1, 1405-1487.
Gaynor, M., & Vogt, W. B. (2003). Competition among hospitals: National Bureau of Economic Research.
Gowrisankaran, G., & Town, R. J. (2003). Competition, Payers, and Hospital Quality1. Health Services Research, 38(6p1), 1403-1422.
Gruber, J. (1992). The Effect of Price Shopping in Medical Markets: Hospital Responses to PPOs in California: National Bureau of Economic Research, Inc.
Huang, C.-C., Cheng, K.-F., & Wu, H.-D. I. (2008). Survival analysis: comparing peritoneal dialysis and hemodialysis in Taiwan. Peritoneal Dialysis International, 28(Supplement 3), S15-S20.
Kessler, D. P., & McClellan, M. B. (1999). Is hospital competition socially wasteful? : National bureau of economic research.
Knaus, W. A., Draper, E. A., Wagner, D. P., & Zimmerman, J. E. (1986). An evaluation of outcome from intensive care in major medical centers. Annals of internal medicine, 104(3), 410-418.
Lindberg, C., Downham, G., Buscell, P., Jones, E., Peterson, P., & Krebs, V. (2013). Embracing collaboration: a novel strategy for reducing bloodstream infections in outpatient hemodialysis centers. American journal of infection control, 41(6), 513-519.
Luft, H. S., & Maerki, S. C. (1984). Competitive potential of hospitals and their neighbors. Contemporary Economic Policy, 3(2), 89-102.
Luft, H. S., Phibbs, C. S., Garnick, D. W., & Robinson, J. C. (1990). Rejoinder to Dranove and Shanley. Journal of Health Economics, 8(4), 479-483.
Lynk, W. J. (1995). Nonprofit hospital mergers and the exercise of market power. Journal of Law and Economics, 437-461.
McDonald, S. P., Marshall, M. R., Johnson, D. W., & Polkinghorne, K. R. (2009). Relationship between dialysis modality and mortality. Journal of the American Society of Nephrology, 20(1), 155-163.
Melnick, G. A., & Zwanziger, J. (1988). Hospital behavior under competition and cost-containment policies: the California experience, 1980 to 1985. Jama, 260(18), 2669-2675.
Nadzam, D. M., Turpin, R., Hanold, L. S., & White, R. E. (1993). Data-driven performance improvement in health care: the Joint Commission's Indicator Measurement System (IMSystem). The Joint Commission journal on quality improvement, 19(11), 492-500.
Noether, M. (1988). Competition among hospitals. Journal of Health Economics, 7(3), 259-284.
Phibbs, C. S., & Robinson, J. C. (1993). A variable-radius measure of local hospital market structure. Health Services Research, 28(3), 313.
Propper, C., Burgess, S., & Gossage, D. (2008). Competition and quality: Evidence from the NHS internal market 1991–9*. The Economic Journal, 118(525), 138-170.
Robinson, J. C., & Luft, H. S. (1985). The impact of hospital market structure on patient volume, average length of stay, and the cost of care. Journal of Health Economics, 4(4), 333-356.
Robinson, J. C., & Luft, H. S. (1987). Competition and the cost of hospital care, 1972 to 1982. Jama, 257(23), 3241-3245.
Robinson, J. C., & Luft, H. S. (1988). Competition, regulation, and hospital costs, 1982 to 1986. Jama, 260(18), 2676-2681.
Robinson, J. C., Luft, H. S., McPhee, S. J., & Hunt, S. S. (1988). Hospital competition and surgical length of stay. Jama, 259(5), 696-700.
Sari, N. (2002). Do competition and managed care improve quality? Health economics, 11(7), 571-584.
Tay, A. (2003). Assessing competition in hospital care markets: the importance of accounting for quality differentiation. RAND Journal of Economics, 786-814.
Teng, A.-T., Chang, R.-E., & Lee, C.-H. (2010). Dialysis Modality and Patient Survival: An Epidemiology Perspective. Acta Nephrologica, 24(1), 1-8.
United States Renal Data System.(2012). Annual Data Report: Altas of End-Stage Renal Disease. From http://www.usrds.org/atlas12.aspx
Vogt, W. B., & Town, R. (2006). How has hospital consolidation affected the price and quality of hospital care?
Zwanziger, J., Melnick, G., & Eyre, K. M. (1994). Hospitals and antitrust: defining markets, setting standards. Journal of Health Politics, Policy and Law, 19(2), 423-447.
Zwanziger, J., & Melnick, G. A. (1988). The effects of hospital competition and the Medicare PPS program on hospital cost behavior in California. Journal of Health Economics, 7(4), 301-320.
Zwanziger, J., Melnick, G. A., & Mann, J. M. (1990). Measures of hospital market structure: a review of the alternatives and a proposed approach. Socio-economic planning sciences, 24(2), 81-95.
中央健保署(2013)。101年門診透析總額專業醫療服務品質報告。取自:http://www.nhi.gov.tw/
中央健保署(2015)。全民健康保險醫療品質資訊公開網。取自:http://www.nhi.gov.tw/mqinfo/Content.aspx?List=1&Type=Dialysis
中央健保署(2015)。103年度全民健康保險慢性腎衰竭病人門診透析服務品質提升獎勵計畫。取自:http://www.nhi.gov.tw/mqinfo/Content.aspx?List=1&Type=Dialysis
毛慶生、朱敬一、林全等 (2001)。 經濟學 。 台北:華泰書局。
王敏容、王如萱、王佳惠、郭乃文 (2005)。 市場競爭程度對醫院開發自費醫療服務之影響。北市醫學雜誌, 2(10),頁 895-906。
李靜玟、吳肖琪 (2005)。 市場競爭及其他因素對精神科急性住院病患醫療利用之影響。臺灣公共衛生雜誌, 24(4),頁 296-305。
林明彥、黃尚志 (2007)。 台灣慢性腎臓病/末期腎臓病流行病學過去, 現在與未來。腎臟與透析, 19(1),頁 1-5。
周麗華、李聰明 (2013)。 血液透析室之感染管制措施。醫療品質雜誌, 7(2),頁 56-61。
許績天、連賢明 (2007)。 賺得越少, 洗得越多?-台灣血液透析治療的誘發性需求探討。經濟論文叢刊, 35(4),頁 415-450。
陳啟禎、鄭守夏 (2008)。 醫療市場競爭的測量: 從市場劃區與競爭指標著手。臺灣公共衛生雜誌, 27(4),頁 292-300。
鈕淑芬 (2004)。 透析病患之生活品質及其相關因素探討。臺灣腎臟護理學會雜誌, 3(2),頁 88-101。
楊樹昌、王榮德、吳麥斯、郭佩雯、蘇喜 (2007)。 長期血液透析病患的生活品質。臺灣醫學, 11(2),頁 140-152。
廖秋萍、蔣偉姣、陳淑娟 (2006)。 腹膜透析病患生活品質及其相關因素探討。臺灣腎臟護理學會雜誌, 5(1),頁 22-39。
衛生福利部(2013)。中華民國101年版公共衛生年報。取自:http://www.mohw.gov.tw/CHT/Ministry/Index.aspx
蔡偉德、李一鑫 (2002)。 醫院非價格性競爭與市場結構: 醫院購置高科技醫療儀器之實證研究。經濟論文, 30(1),頁 57-78。
盧瑞芬、謝啟瑞 (2003)。 台灣醫院產業的市場結構與發展趨勢分析。經濟論文叢刊, 31(1),頁 107-153。


連結至畢業學校之論文網頁點我開啟連結
註: 此連結為研究生畢業學校所提供,不一定有電子全文可供下載,若連結有誤,請點選上方之〝勘誤回報〞功能,我們會盡快修正,謝謝!
QRCODE
 
 
 
 
 
                                                                                                                                                                                                                                                                                                                                                                                                               
第一頁 上一頁 下一頁 最後一頁 top
1. 李靜玟、吳肖琪 (2005)。 市場競爭及其他因素對精神科急性住院病患醫療利用之影響。臺灣公共衛生雜誌, 24(4),頁 296-305。
2. 林明彥、黃尚志 (2007)。 台灣慢性腎臓病/末期腎臓病流行病學過去, 現在與未來。腎臟與透析, 19(1),頁 1-5。
3. 周麗華、李聰明 (2013)。 血液透析室之感染管制措施。醫療品質雜誌, 7(2),頁 56-61。
4. 許績天、連賢明 (2007)。 賺得越少, 洗得越多?-台灣血液透析治療的誘發性需求探討。經濟論文叢刊, 35(4),頁 415-450。
5. 陳啟禎、鄭守夏 (2008)。 醫療市場競爭的測量: 從市場劃區與競爭指標著手。臺灣公共衛生雜誌, 27(4),頁 292-300。
6. 鈕淑芬 (2004)。 透析病患之生活品質及其相關因素探討。臺灣腎臟護理學會雜誌, 3(2),頁 88-101。
7. 楊樹昌、王榮德、吳麥斯、郭佩雯、蘇喜 (2007)。 長期血液透析病患的生活品質。臺灣醫學, 11(2),頁 140-152。
8. 廖秋萍、蔣偉姣、陳淑娟 (2006)。 腹膜透析病患生活品質及其相關因素探討。臺灣腎臟護理學會雜誌, 5(1),頁 22-39。
9. 蔡偉德、李一鑫 (2002)。 醫院非價格性競爭與市場結構: 醫院購置高科技醫療儀器之實證研究。經濟論文, 30(1),頁 57-78。
10. 盧瑞芬、謝啟瑞 (2003)。 台灣醫院產業的市場結構與發展趨勢分析。經濟論文叢刊, 31(1),頁 107-153。